News
2 minute read

MBHB Partner Kevin Noonan Quoted in TheAtlantic.com Article Entitled, “Why the University of California Is Appealing the CRISPR Patent Decision"

McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in an April 13, 2017 edition of TheAtlantic.com in an article entitled, “Why the University of California Is Appealing the CRISPR Patent Decision.” So it continues. In February, the U.S. Patent and Trademark Office decided in favor of the Broad Institute of Harvard and the Massachusetts Institute of Technology, which has been battling for years with the University of California over patents for the gene-editing technology CRISPR-Cas9, often shorthanded as CRISPR. View the article